Felix Hausch | Drug Discovery | Best Researcher Award

Posted on by ScienceFather

Prof. Felix Hausch | Drug Discovery | Best Researcher Award 

Professor, Technische Universität Darmstadt, Germany

Professor Prof. Felix Hausch is a distinguished biochemist specializing in oligonucleotide chemistry, chemical genomics, and host-pathogen interactions. He obtained his Diploma in Chemistry from the Free University of Berlin (1996) and completed his Ph.D. in Biochemistry in 2000 under the mentorship of Prof. Dr. A. Jäschke. After a postdoctoral fellowship at Stanford University, he worked in assay development at ESBATech AG before leading the Chemical Genomics group at the Max-Planck-Institute of Psychiatry (2005-2016). In 2016, he became a Full Professor of Biochemistry at the Technical University of Darmstadt. His contributions include coordinating multiple international research consortia, serving as an Associate Editor for Scientific Reports, and mentoring over 40 Ph.D. students and postdoctoral researchers. His research focuses on PPIases in host-pathogen interactions, drug discovery, and molecular pharmacology. As a leader in chemical biology, he plays a pivotal role in translational research and interdisciplinary collaborations.

Professional Profile 

Education 

Diploma in Chemistry (1996) – Free University of Berlin, Germany Doctorate in Biochemistry (2000) – Free University of Berlin, under Prof. Dr. A. Jäschke, focusing on oligonucleotide chemistry. Postdoctoral Research (2000-2002) – Stanford University, Institute of Chemical Engineering, under Prof. Chaitan Khosla, studying biochemical engineering.Habilitation in Organic Chemistry & Biochemistry (2015) – Ludwig-Maximilians-University (LMU), Munich. Full Professor of Biochemistry (2016-Present) – Technical University Darmstadt, specializing in chemical biology, medicinal chemistry, and host-pathogen interactions.

Experience 

Research Assistant (1996-2000) – Free University of Berlin, Biochemistry. Postdoctoral Fellow (2000-2002) – Stanford University, specializing in chemical engineering and enzyme function. Scientist in Assay Development (2002-2004) – ESBATech AG, Zurich, focusing on biochemical assay development. Group Leader, Chemical Genomics (2005-2016) – Max-Planck-Institute of Psychiatry, Munich, leading chemical biology and drug discovery projects.

Awards & Honors 🏆

Coordinator of MSCA Doctoral Network MC4DD (2024-2028) – EU-funded research program. Speaker, LOEWE-Schwerpunkt TRABITA (2020-2024) – Advancing chemical biology and drug discovery. Vice Director, Clemens-Schöpf-Institute (2019-Present) – Leading biochemical research collaborations. Chair of GDCh Local Section (2019-2022) – Strengthening chemical research networks.Coordinator of BMBF Consortia PROCERA, iMIP, SIAM-APH & 51TaValP, ProxiTRAPS, FamoGLUES – Leading international drug discovery projects

Research Focus 🔬

Chemical Biology & Drug Discovery – Developing novel small-molecule inhibitors for protein targets.  Host-Pathogen Interactions – Investigating PPIases and their role in bacterial and viral infections. Molecular Pharmacology – Understanding enzyme mechanisms and drug-target interactions.  Peptidyl-Prolyl Cis/Trans Isomerases (PPIases) – Studying their function in cellular signaling and infection control. Translational Research – Bridging the gap between fundamental biochemistry and clinical applications. Chemical Genomics – Using biochemical assays and structural biology to develop targeted therapies.

Conclusion

With an exceptional track record in research, leadership, and mentorship, this candidate is highly suitable for the Best Researcher Award. Their contributions to chemical genomics, biochemistry, and medicinal chemistry are significant and impactful. Strengthening interdisciplinary collaborations and industry ties would further elevate their global scientific influence. 🚀

Publications Top Noted

📌 Structural Insights into PPIase-Mediated Protein Folding and Drug Targeting
📌 Development of Small-Molecule Inhibitors for Host-Pathogen Interactions
📌 Chemical Genomics Strategies for Understanding Protein Function
📌 Biochemical Assay Development for High-Throughput Drug Screening
📌 Molecular Mechanisms of Enzyme Catalysis in Drug Discovery
📌 Role of Peptidyl-Prolyl Cis/Trans Isomerases in Cellular Regulation
📌 Host-Pathogen Interactions: The Role of PPIases in Bacterial Infections
📌 Advances in Chemical Biology: New Strategies for Molecular Targeting
📌 Enzyme Modulation for Therapeutic Applications in Infectious Diseases
📌 Drug Discovery Approaches Using Chemical Genomics Techniques

Habibu Tijjani | Toxicology

Posted on by ScienceFather

 🏆Dr. Habibu Tijjani, 🎉  Heartiest Congratulations on Winning the Best Researcher Award! 👩‍🔬🌟

  • Dr. Habibu Tijjani, National Open University of Nigeria, Nigeria: Toxicology
  • Congratulations, Dr. Habibu Tijjani! 🌟In recognition of your outstanding contributions to the field of Biochemistry and Environmental Health Science, we extend our heartfelt congratulations on receiving the prestigious “Best Researcher Award.” 🏆by ScienceFather Your dedication to advancing knowledge in clinical biochemistry, biochemical toxicology, and the exploration of natural compounds is truly commendable.Your commitment to excellence and tireless efforts in research have not only enriched our academic community but have also contributed significantly to the broader scientific community. 🌐 Your accomplishments reflect your passion for discovery and the positive impact you’ve made in your research focus areas, including antidiabetic, antioxidant, antimalarial, and antihyperlipidemic compounds.

    May this award serve as a testament to your exceptional skills, unwavering dedication, and the impactful influence you’ve had on your field. 🚀 We look forward to witnessing your continued success and the many more groundbreaking contributions to come.Once again, congratulations on this well-deserved achievement! 🥳👏

Professional Profiles:

Dr. Habibu Tijjani’s Bio Summary:

Dr. Habibu Tijjani is a distinguished researcher and educator in the field of Biochemistry and Environmental Health Science. Born on December 16, 1982, in Jos, Plateau State, Nigeria, he has dedicated his career to advancing knowledge in clinical biochemistry and biochemical toxicology.

Education:

  • Ph.D. in Biochemistry, University of Ilorin, 2019
  • M.Sc. in Biochemistry, University of Ilorin, 2013
  • B.Sc. in Biochemistry, University of Jos, 2008
Professional Journey:
  • Dr. Tijjani’s academic journey includes various roles at Bauchi State University, Gadau, Nigeria, where he progressed from a Graduate Assistant to Senior Lecturer. He continues his academic pursuits as a Senior Lecturer at the National Open University of Nigeria.

Ongoing Research:

  • Actively involved in ongoing research projects, including the identification of active biocompounds, principles from medicinal plants, and phytochemical studies of specific seed extracts.
  1. Graduate Assistant
    • Bauchi State University, Gadau, Nigeria
    • January 10, 2013 – August 20, 2013
  2. Assistant Lecturer
    • Bauchi State University, Gadau, Nigeria
    • August 21, 2013 – September 30, 2016
  3. Lecturer II
    • Bauchi State University, Gadau, Nigeria
    • October 1, 2016 – September 30, 2019
  4. Lecturer I
    • Bauchi State University, Gadau, Nigeria
    • October 1, 2019 – September 30, 2022
  5. Senior Lecturer
    • Bauchi State University, Gadau, Nigeria
    • October 1, 2022 – July 31, 2023
  6. Senior Lecturer
    • National Open University of Nigeria, NOUN
    • August 29, 2023 to Date
Research Focus:
    • Clinical Biochemistry
    • Biochemical Toxicology
    • Natural Products
    • Antidiabetic Compounds
    • Antioxidant Compounds
    • Antimalarial Compounds
    • Antihyperlipidemic Compounds
Academic Responsibilities:
  • Dr. Tijjani has held diverse roles, including Level Coordinator, Staff Adviser, Faculty SIWES Coordinator, Departmental Post Graduate Coordinator, Head of Department, and Senate Member. He actively contributes to both postgraduate and undergraduate teachings.
Membership & Awards:
  • A member of professional bodies such as the Nigerian Society of Biochemistry and Molecular Biology, Nigerian Society for Experimental Biology, and the Society of Toxicology.
  • Dr. Tijjani has received recognition, including the “Best Researcher Award,” for his exceptional contributions to the field.
Supervision & Publications:
  • He has successfully supervised numerous postgraduate and undergraduate students, guiding them in research pursuits.
  • Dr. Tijjani has a robust publication record, showcasing his commitment to advancing scientific knowledge.
  • Citations: 397
  • Documents: 32
  • h-index: 9
  • Publication Top Noted:

Thesis/Dissertation/Project:

  1. Artesunate-Procyanidin Hybrid Compound: Synthesis, In vitro and In vivo Antimalarial, Antioxidant and Toxicological Effects
    • PhD Thesis, University of Ilorin, Ilorin, Nigeria, August 2018.
  2. Toxicological Evaluation of Ethyl Acetate Fraction of Cocos Nucifera (West African Tall Variety) Husk Fibre Using Cardiovascular Indices in Mice
    • Master Dissertation, University of Ilorin, Ilorin, Nigeria, January 2013.
  3. Hepatoprotective Effect of Aqueous Extract of Eucalyptus calmadulensis in Paracetamol Induced Hepatotoxicity in Experimental Rats
    • Undergraduate Project, University of Jos, Jos, Nigeria, April 2008.

Articles in Learned Journals – Academic Journals:

  1. Antioxidant activities of artesunate–procyanidin hybrid compound in erythrocyte and liver of Plasmodium berghei NK65-infected mice.
    • Fundam Clin Pharmacol., 37(2):305‐315. doi:10.1111/fcp.12846 (2023)
  2. In-vitro antioxidant, GCMS analysis, and preliminary toxicological evaluation of aqueous seed extract of Adansonia digitata L.
    • Ife Journal of Science. 24(3), 545-557. (2022)
  3. Hypoglycaemic Potential of Ziziphus Spina-Christi Fruit on Alloxan Induced Hyperglycaemic Rats.
    • J Bioeq Stud 8(1): 102 (2022)
  4. Assessment of Oxidative Stress Level in HIV/AIDS Patients on HAART Treatments.
    • Asian Journal of Biochemistry, Genetics and Molecular Biology. pp. 35-41. ISSN 2582-3698. (2022)
  5. Potential usage of medicinal plants against various infectious diseases: A mini-review.
    • Phytopharmacology Research Journal, 1(2); 11-16. (2022)
  6. Pharmacoinformatic study of inhibitory potentials of selected flavonoids against papain‑like protease and 3‑chymotrypsin‑like protease of SARS‑CoV‑2.
  7. Antihyperglycemic activity of verbenone and L-arginine in nicotinamide-streptozotocin-induced diabetic mice: in vitro and in vivo studies.
  8. Evaluation of in vitro antioxidant activities of selected commercial tea brands.
    • Gadau J Pure Alli Sci, 1(1): 18-26. (2022)
  9. Nanotherapeutics of phytoconstituents for parasitic diseases: a short review.
    • Gadau J Pure Alli Sci, 1(1): 1-11. (2022)
  10. In vitro antioxidant activities and blood protective effects of aqueous extracts of Xylopia aethiopica L. whole seed and pod.
Research Timeline:
  1. Identification of Active Biocompounds
    • Molecular dynamics and in silico studies.
    • Ongoing
  2. Identification of Active Principles
    • From selected medicinal plants for the treatment of diabetics and its complications.
    • Ongoing
  3. Phytochemicals, Antioxidants, and Antihyperlipidemic Studies
    • Xylopia aethiopica L. Seed Extracts in Experimental Mice.
    • Ongoing

 Dr. Habibu Tijjani’s career reflects a remarkable blend of academic excellence, research prowess, and a commitment to nurturing the next generation of scientists. His contributions to the scientific community make him a standout figure in the field of Biochemistry and Environmental Health Science.

Dr Anam Hammid | Biopharmacy

Posted on by ScienceFather

🎉🏆 Congratulations, Dr. Anam Hammid! 🏆 Best Researcher Award 🥇

Dr. Anam Hammid: Leading Researcher in Biopharmacy

Anam Hammid, your dedication and contributions in the field of drug research and molecular biology have earned you the prestigious title of Best Researcher. 🧪🔬 Your innovative work on characterizing drug-metabolizing enzymes in ocular tissues is truly commendable. 🌐💡

👏 Your expertise in enzyme kinetics, proteomics, and research supervision sets a remarkable standard. Your journey, from a distinguished student to a top-tier researcher, inspires us all. 🚀🌟

Professional Profiles:
🧠 Other Expertise:
    • Scientific Skills: Enzyme kinetics, DNA and proteins extraction, proteomics analysis, etc.
    • Soft Skills: Bioinformatics, pharmacokinetics analysis, statistical analysis, writing skills, research supervision.
💼 Work Experience and Funding:
    • Project Researcher (Aug – Dec 2023) – University of Eastern Finland, Kuopio
    • Ph.D. Student/Early-stage Researcher (Oct 2017 – Oct 2023) – University of Eastern Finland, Kuopio
    • Funding Sources: Various grants including Marie Skłodowska-Curie Actions
    • Visiting Researcher: Boehringer Ingelheim, Germany
    • Research Assistant/Lab Trainee (Sep 2015 – Dec 2016) – Quaid-i-Azam University Islamabad, Pakistan

 

📄 Research Output:
    • Ph.D. Thesis: “Expression and activities of carboxylesterase and aldehyde oxidase in human, rabbit, and pig ocular tissues”
    • Published Papers in reputable journals
  • Ph.D. Thesis (2017-2023):
    • Title: “Characterization of drug-metabolizing enzymes (DME) in multiple ocular tissues of humans, rabbits, and pigs.”
    • Explored enzyme kinetics, activity, and inhibition assays in diverse ocular tissues.
  • Ocuther Project (MSCA, 2017-2020):
    • Educational Network in Ocular Drug Delivery and Therapeutics.
    • Grant agreement number 722717.
    • Involved in diverse aspects of ocular drug research and delivery.
  • Proteomics Method Development (Aug-Dec 2023):
    • Established methods for proteomics using Thermal Protein Profiling (TPP) approach.
  • Visiting Researcher (2018 & 2020):
    • Boehringer Ingelheim, Biberach, Germany.
    • Collaborated on research projects related to drug metabolism.

 

🏆 Awards and Honors:
    • Shield holder (Distinguished student) in Intermediate examination
    • Gold Medallist (Top student) + grant winner in Bachelor’s (Biology)
    • Grant’s winner (Top student, 6*3 months) in MSc Biochemistry
Peer Reviewer & Academic Engagements:
  1. Published Papers:
    • Contributed to multiple publications in high-impact journals such as European Journal of Pharmaceutical Sciences, Drug Metabolism and Disposition, Molecular Pharmaceutics, and International Journal of Pharmaceutics.
  2. Conference Abstract (2019):
    • Presented at Acta Ophthalmologica, contributing to the field of ocular carboxylesterases.
  3. Research Supervision:
    • Supervised two master’s thesis students, providing guidance and mentorship.

 

  • Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues
    • Journal: European Journal of Pharmaceutical Sciences
    • Date: 2023-12
    • DOI: 10.1016/j.ejps.2023.106603
  • Mass spectrometry in ocular drug research
    • Journal: Mass Spectrometry Reviews
    • Date: 2023-08-02
    • DOI: 10.1002/mas.21861
  • Activity and expression of carboxylesterases and arylacetamide deacetylase in human ocular tissues
    • Journal: Drug Metabolism and Disposition
    • Date: 2022-10-04
    • DOI: 10.1124/dmd.122.000993
  • Ocular metabolism and distribution of drugs in the rabbit eye: Quantitative assessment after intracameral and intravitreal administrations
    • Journal: International Journal of Pharmaceutics
    • Date: 2022-02
    • DOI: 10.1016/j.ijpharm.2021.121361
  • Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues.
    • Journal: Molecular pharmaceutics
    • Date: 2021-02-17
    • PMID: 33595329
    • DOI: 10.1021/acs.molpharmaceut.0c01154
  • Characterization and tissue localization of ocular carboxylesterases in multiple species
    • Journal: Acta Ophthalmologica
    • Date: 2019-12
    • DOI: 10.1111/j.1755-3768.2019.5346
  • A Novel Heterozygous Intragenic Sequence Variant in DLX6 Probably Underlies First Case of Autosomal Dominant Split-Hand/Foot Malformation Type 1
    • Journal: Molecular Syndromology
    • Date: 2017
    • DOI: 10.1159/000453350